Brendan Watson, Ms
About Brendan Watson, Ms
Brendan Watson is a Senior Associate in Regulatory Affairs at BeiGene, with a background in biotechnology and regulatory affairs.
Current Role at BeiGene
Brendan Watson currently serves as a Senior Associate in Regulatory Affairs at BeiGene. This position, which he transitioned to in August 2021, is conducted remotely. BeiGene is known for its work in the biotechnology sector, focusing on developing molecularly targeted and immuno-oncology drug candidates.
Previous Experience at Progenity, Inc.
Before joining BeiGene, Brendan Watson worked at Progenity, Inc. as a Regulatory Affairs Specialist from 2020 to 2021. Prior to this role, he served as a Clinical Trials Associate at the same company from 2018 to 2020. Progenity is recognized for its innovations in the field of precision medicine and diagnostics.
Clinical Research and Coordination at GenomeDx Biosciences
Brendan Watson's career path also includes a role as a Clinical Research Coordinator at GenomeDx Biosciences Inc., where he worked for three years from 2015 to 2018. GenomeDx is a leader in genomic testing and precision medicine, known for its work in the scientific community.
Early Career Roles and Industry Exposure
Early in his career, Brendan Watson gained diverse experience through multiple roles. He worked as a Manufacturing Associate at Thermo Fisher Scientific in 2015, and as a Mover at Behr Moving in Phoenix, Arizona in 2014. Additionally, he contributed to research aimed at detecting early signs of autism through joint attention at Arizona State University from 2012 to 2013.
Academic Background and Specialized Training
Brendan Watson holds a Master of Science in Biotechnology Regulatory Affairs from the University of Maryland University College, completed between 2018 and 2020. He also earned a Bachelor of Science in Biomedical and Health Systems Engineering from Arizona State University, completed in 2013. His formal education focused on regulatory strategy, product development, scientific concepts, and leadership, providing a strong foundation for his current role in regulatory affairs.